Freshly Printed - allow 10 days lead
Couldn't load pickup availability
Specification of Drug Substances and Products
Development and Validation of Analytical Methods
A comprehensive analysis of the requirements and approaches to setting specifications for new pharmaceutical products
Christopher M. Riley (Edited by), Thomas W. Rosanske (Edited by), George L. Reid (Edited by)
9780081028247, Elsevier Science
Paperback, published 24 July 2020
694 pages, 175 illustrations (15 in full color)
23.4 x 19 x 4.2 cm, 1.54 kg
Specification of Drug Substances and Products: Development and Validation of Analytical Methods, Second Edition, presents a comprehensive and critical analysis of the requirements and approaches to setting specifications for new pharmaceutical products, with an emphasis on phase-appropriate development, validation of analytical methods, and their application in practice. This thoroughly revised second edition covers topics not covered or not substantially covered in the first edition, including method development and validation in the clinical phase, method transfer, process analytical technology, analytical life cycle management, special challenges with generic drugs, genotoxic impurities, topical products, nasal sprays and inhalation products, and biotechnology products. The book's authors have been carefully selected as former members of the ICH Expert Working Groups charged with developing the ICH guidelines, and/or subject-matter experts in the industry, academia and in government laboratories.
PART 1 INTRODUCTION 1. Introduction 2. General Principles and Regulatory Considerations: Specifications and Shelf Life Setting 3. General Principles and Regulatory Considerations: Method Development and Validation 4. Application of Quality by Design (QbD) to the Development and Validation of Analytical Methods 5. Analytical Methods in the Clinical Phase of Development 6. Method Transfer 7. Process Analytical Technology PART 2 UNIVERSAL TESTS 8. Description and Identification 9. Assay and Impurities: Specifications 10. Assay and Impurities: Method Development and Life-Cycle Management 11. Assay and Impurities: Method Validation 12. Mutagenic Impurities 13. Residual Solvents 14. Inorganic Impurities (Elemental Impurities) PART 3 SPECIFIC TESTS: DRUG SUBSTANCES 15. Solid State Characterization 16. Chiral Methods 17. Water Determination PART 4 SPECIFIC TESTS DRUG PRODUCT 18. Drug Release: Oral Products 19. Topical Products 20. Extractables and Leachables PART 5 BIOTECHNOLOGY PRODUCTS 21. Regulatory Requirements for Setting Drug Substance and Drug Product Specifications 22. Validation of Analytical Methods for Biotechnology Products PART 6 PHARMACOPEIAL METHODS 23. Pharmacopeial Methods and Test (Updated) PART 7 BIOLOGICAL FLUIDS 24. Biological Fluids
Subject Areas: Pharmaceutical technology [TDCW], Organic chemistry [PNN], Analytical chemistry [PNF], Chemistry [PN], Pharmacology [MMG]
